| Transplantation: State of the Art |
|
|
Hematopoietic Cell Transplantation: The First 50 Years and a Glimpse of the Future |
|
|
3 | (8) |
|
|
|
|
|
|
Current Status of Blood and Marrow Transplantation |
|
|
11 | (14) |
|
|
|
|
|
| Stem Cells and Growth Factors |
|
|
Normal and Leukemic Human Stem Cells |
|
|
25 | (12) |
|
|
|
|
|
|
Thrombopoietic Growth Factors - Managing Thrombocytopenia |
|
|
37 | (13) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Erythropoietin Use in Therapy of Anemia Associated with Bone Marrow Transplantation in Children |
|
|
50 | (7) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Autotransplantations of Peripheral Blood Progenitor Cells, Collected After Mobilization by Single-Dose Betaleukin (rh-IL-1b) |
|
|
57 | (8) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stem Cells: Donors and Sources |
|
|
Allogeneic Cord Blood Hematopoietic Stem Cell Transplants in Malignancies |
|
|
65 | (13) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Future Source of Allogeneic Stem Cells: Bone Marrow or Peripheral Blood? |
|
|
78 | (5) |
|
|
|
|
|
|
Marrow Unrelated Donor Transplantation: European Experience |
|
|
83 | (14) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Immune Effects and Cellular Immune Therapy |
|
|
New Strategies for Hematopoietic Stem Cell Transplantation |
|
|
97 | (15) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nonmyeloablative Allogeneic Stem Cell Transplantation: Towards Improving Efficacy of Immunotherapy Instead of Myeloablative Chemoradiotherapy |
|
|
112 | (6) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Autologous Peripheral Blood Stem Cell Transplantation in Childhood Metastatic Osteosarcoma |
|
|
118 | (5) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mycophenolate Mofetil for the Treatment of Acute and Chronic GVHD in Bone Marrow Transplant Patients |
|
|
123 | (7) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Peripheral Blood and Bone Marrow Derived Dendritic Cells in Acute Myelogenous Leukemia |
|
|
130 | (7) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Minimal Residual Disease: Detection and Treatment |
|
|
|
|
137 | (8) |
|
|
|
|
|
|
Autologous Stem Cell Transplantation and Cell Therapy for Acute Leukemia |
|
|
145 | (14) |
|
|
|
|
|
|
Positive Selection of Hematopoietic Progenitor Cells for Autologous and Allogeneic Transplantation in Pediatric Patients with Solid Tumors and Leukemia |
|
|
159 | (10) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Simultaneous Double-Purging of Breast Cancer Cells from Leukapheresis Products by Imunomagnetic CD34+ Cell Enrichment and Tumor Cell Depletion |
|
|
169 | (6) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Immunomagnetic Purging of Marrow and Peripheral Blood Progenitors for Autografting in Patients with Lymphoproliferative Disorders-Selection Efficacy and Engraftment |
|
|
175 | (6) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Establishment of an NOD/SCID Mouse Model for Ewing Tumors: A Potential Preclinical Model to Test Novel Purging Strategies |
|
|
181 | (4) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Molecular Genetic Detection of Minimal Metastatic and Residual Disease in Ewing's Tumors |
|
|
185 | (11) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Molecular Monitoring of Treatment Efficacy after Hematopoietic Stem Cell Transplantation in Chronic Myeloid Leukemia |
|
|
196 | (7) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Detection of Residual Tumor Cells by RT-PCR for Tyrosine Hydroxylase mRNA |
|
|
203 | (8) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Autologous Transplantation in Leukemias, Lymphomas, and Solid Tumors |
|
|
Autograft Followed by Allograft Without Myeloablative Conditioning Regimen: A New Approach for Resistant Hematologic Neoplasia and Breast Cancer |
|
|
211 | (6) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Possible Prognostic Benefit from ABMT in First Remission Adult Acute Lymphoblastic Leukemia |
|
|
217 | (9) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
G. Lambertenghi-Deliliers |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Updated Results of an Age-Adapted Consolidation Strategy with ABMT (< 50 Years) or High-Dose Ara-C (HiDAC, > 50 Years) in Adult Acute Myeloid Leukemia </ 50 Years) or High-Dose Ara-C (HiDAC, > |
|
|
226 | (6) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mobilization of Peripheral Blood Stem Cells after Intensive Induction and Consolidation Therapy in Adult Patients with De Novo Acute Myeloid Leukemia |
|
|
232 | (7) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Autologous Stem Cell Transplantation in Acute Promyelocytic Leukemia Patients Achieving a Second Complete Remission |
|
|
239 | (9) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Autologous Hematopoietic Cell Transplantation for Lymphoid Malignancies |
|
|
248 | (4) |
|
|
|
|
|
|
Dexa-BEAM with High-Dose Cytarabine and Autologous Bone Marrow Transplantation are Highly Effective in Heavily Pretreated Poor-Prognosis Lymphoma Patients |
|
|
252 | (6) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Delayed Granulocyte Recovery and Suppressed Growth of Grafted CFU-GM If Allogeneic Marrow Cells are Transplanted 48 h After the Completion of High-Dose Busulfan and Cyclophosphamide (BuCy2) Therapy |
|
|
258 | (6) |
|
|
|
|
|
|
|
|
|
|
|
High-Dose Chemotherapy for Primary Metastatic or Relapsed Ewing Tumours: Outcome of 120 (EI)CESS Patients |
|
|
264 | (8) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Autologous Peripheral Blood Stem Cell Transplantation in Childhood Metastatic Osteosarcoma |
|
|
272 | (7) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Approaches to Gene Therapy |
|
|
Retroviral Transfer and Expression of Drug Resistance Genes in Hematopoietic Cells |
|
|
279 | (8) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gene Therapy with Cord Blood Hematopoietic Stem Cells for Adenosine Deaminas Deficiency: An Update |
|
|
287 | (5) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adenovirus Mediated p53 (Adp53) Gene Transfer |
|
|
292 | (11) |
|
|
|
|
|
|
Pharmacological Gene Therapy for Experimental Brain Tumors |
|
|
303 | (12) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transgenic Expression of IL-2 in Peripheral Neuroectodermal Malignancies of Childhood: In Vitro and In Vivo Effects on Lymphocyte Activation and Tumor Lysis |
|
|
315 | (13) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Suicide Gene Transduced T-Cells for the Regulation of the Graft-Versus-Leukemia Effect |
|
|
328 | (5) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Defining Current Strategies for Future Human Trials in Gene Therapy |
|
|
333 | (4) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subject Index |
|
337 | |